Kate Park / TechCrunch:
ImpriMed, which builds AI-powered drug response prediction tech to assist deal with most cancers in canines and cats, raised a $23M Sequence A led by SoftBank Ventures Asia — ImpriMed, a California-based precision medication startup, builds AI-powered canine most cancers remedy know-how that helps veterinarians determine …
[ad_2]